Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenosine receptors are a family of G protein-coupled receptors (GPCRs) that mediate the physiological actions of adenosine, an endogenous purine nucleoside involved in numerous biological processes. There are four well-characterized subtypes of adenosine receptors: A1 (ADORA1), A2A (ADORA2A), A2B (ADORA2B), and A3 (ADORA3). Each subtype is encoded by a distinct gene and exhibits unique tissue distribution, pharmacological properties, and signaling mechanisms. They are important drug targets across multiple therapeutic areas due to their widespread physiological roles.
Agonism or antagonism of adenosine receptors, modulating adenylyl cyclase activity and downstream signaling pathways.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine Receptor.